SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENSET - GENXY -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (184)5/28/2001 4:15:45 AM
From: Michael P. Michaud  Read Replies (1) | Respond to of 200
 
nice link. i am a big fan of ahahha's, followed his posts since 1998 as well, when i got into at home. he always has a contrarian angle. i appreciate thinkers like that. you have to be visionary in order to succeed in this market today. problem is that the story changes so quickly, that one has to be nimble. that was my mistake with genset, but it is no use selling now (or at $3, for that matter). i did learn one very painful lesson: never buy a foreign adr, it is useless to be nimble with these issues.



To: Mike McFarland who wrote (184)11/3/2001 11:24:45 AM
From: Michael P. Michaud  Respond to of 200
 
anyone else get their 2nd quarter report?
mine came in the mail this morning.
looks like they cloned and expressed apm-1 human protein fragment (famoxin) in e.coli. e.coli best medium for the production of therapeutic proteins.
also they have decided not to sell oligos division, which is the first rational decision out this company in a long time.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News